Oculis Holding AG (OCS)
30.68
-0.69
(-2.20%)
USD |
NASDAQ |
May 14, 12:11
Oculis EPS Diluted (Quarterly) : -0.625 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.654 |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | -2.339 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.82M |
| Total Expenses (Quarterly) | 36.82M |
| Enterprise Value | 1.545B |
| Earnings Yield | -6.97% |
| Normalized Earnings Yield | -6.570 |